CDY - A Hair Raising Stock

[Minerbarejet]

Thats a big hit boys -wouldnt that just blow your hair back lol - i put this on my watchlist the other day to have time to look at their cashflow statements but never got round to it - i guess they will get a hit if they have to stump up with the law suit $$$$$ against them - its never a win for anyone under these circumstnaces - lets hope it gets cleared up - perhaps give them some free product

Excellent results through. 1.5 m for the last quarter. Cash on hand dropped slightly.
Advangen looks like it is in profit and the whole shebang is virtually cash flow positive without any input from the recently announced US distribution of the hair product.
More tomorrow after the conference call and updates.

[heisenberg]

http://www.cellmid.com.au/SiteMedia/...20Briefing.pdf

Exciting investor presentation.

Highlight (a few of many):
- Sales up 82% in FY2016; revenue growth up 60%
- Evolis showed 75% reduction in hair loss and 40% increase in growing follicles
- Growing Japan sales
- USA e-commerce sales to commence late 2016; direct to consumer channels 2017; target $100m revenue in 5-7yrs
- Preclinical development of Kinera and Lyramid due to be completed
- Experienced management team

My take on it? CDY is the real deal.

[SCHUMACHER]

http://www.cellmid.com.au/SiteMedia/...20Briefing.pdf

Exciting investor presentation.

Highlight (a few of many):
- Sales up 82% in FY2016; revenue growth up 60%
- Evolis showed 75% reduction in hair loss and 40% increase in growing follicles
- Growing Japan sales
- USA e-commerce sales to commence late 2016; direct to consumer channels 2017; target $100m revenue in 5-7yrs
- Preclinical development of Kinera and Lyramid due to be completed
- Experienced management team

My take on it? CDY is the real deal.

yeah but whats the EBIT and NPAT - Thats what matter not just revenues / lots of companies generating revenue but not many making money for growth and expansion - whats the OPEX - ??

do they have a profit guidance ???

cheers Schu

[heisenberg]

Cellmid flying well under the radar.

5th Oct 2016
CELLMID’S MIDKINE ANTIBODIES SHOW ANTI-TUMOUR ACTIVITY AGAINST BRAINCANCER
 Midkine antibodies slow glioblastoma cell growth and reduce brain tumour size
 Data adds to findings that midkine antibodies are effective against multipletumour types alone or in combination with other therapies
 New clinical development and collaboration opportunity for Cellmid

[heisenberg]

Release Date: 10/10/16 11:00
CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS-CDY.AX

- Over $1mil sales for 1Q FY2017 for Cellmid's hair loss products
- Australian sales of evolis up by 115% compared with same period in FY2016

[Minerbarejet]

Options close for trading tomorrow. Be interesting to see what the uptake will be considering the Share Price is matching the Strike Price at the moment.
Looking for Maria pull a rabbit out of the hat tomorrow or is that a hare.
Good time for PEB to announce CMS or KP or even both.

[Minerbarejet]

Most directors taking up all their options so far and some buying more shares as well.
Option Trading closed yesterday.
Expect a proper 4C quarterly before end of month not just that bit about "best ever" sales for Evolis.
This week would be good before the options expire.

[heisenberg]

Yep, hopefully an exciting few weeks ahead now that the options anchor has been lifted. There are some conspiracy theorists who suspect the sp has been intentionally suppressed until this time... let's see if they are right

[stoploss]

Capital raise ....
http://www.asx.com.au/asxpdf/2016102...j4s02ftjnd.pdf

[heisenberg]

CDYO conversion must have fallen short. I don't have a problem with it as long as it's used fund expansion into the competitive US market, but if it is just for day-to-day expenses and CEO's paycheck then I'll be pissed!